Earth Life Sciences Inc (CLTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| TOTAL | $1 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 1 | 1 |
| Intangibles | 4,426 | 176 | 0 | 0 | 0 |
| TOTAL | $4,426 | $176 | $N/A | $1 | $1 |
| Total Assets | $4,427 | $176 | $N/A | $1 | $1 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 245 | 298 | 33 | 33 | 33 |
| Accounts payable and accrued liabilities | 79 | 52 | 57 | 252 | 276 |
| TOTAL | $373 | $378 | $338 | $285 | $309 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $373 | $378 | $338 | $285 | $309 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 960,817 | 464,817 | 332,817 | 332,817 | 270,817 |
| Common Shares | 961 | 465 | 333 | 333 | 271 |
| Retained earnings | -18,705 | -17,121 | -15,293 | -15,239 | -14,801 |
| Other shareholders' equity | 132 | 132 | 132 | 132 | 132 |
| TOTAL | $4,054 | $-202 | $-338 | $-284 | $-308 |
| Total Liabilities And Equity | $4,427 | $176 | $0 | $1 | $1 |